Beloueche-Babari, M., Box, C., Arunan, V., Parkes, H. G., Valenti, M., De Haven Brandon, A., . . . Leach, M. O. (2015). Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours. British Journal of Cancer, 112(7), 1206. https://doi.org/10.1038/bjc.2015.86
Chicago Style (17th ed.) CitationBeloueche-Babari, M., C. Box, V. Arunan, H G. Parkes, M. Valenti, A. De Haven Brandon, L E. Jackson, S A. Eccles, and M O. Leach. "Acquired Resistance to EGFR Tyrosine Kinase Inhibitors Alters the Metabolism of Human Head and Neck Squamous Carcinoma Cells and Xenograft Tumours." British Journal of Cancer 112, no. 7 (2015): 1206. https://doi.org/10.1038/bjc.2015.86.
MLA (9th ed.) CitationBeloueche-Babari, M., et al. "Acquired Resistance to EGFR Tyrosine Kinase Inhibitors Alters the Metabolism of Human Head and Neck Squamous Carcinoma Cells and Xenograft Tumours." British Journal of Cancer, vol. 112, no. 7, 2015, p. 1206, https://doi.org/10.1038/bjc.2015.86.